Kymera Therapeutics Inc
KYMR
Equity
ISIN null / Valor 56388008
NASDAQ (2026-01-27)
USD 72.15+1.53%
Kymera Therapeutics Inc
UMushroom community rating:
About company
Kymera Therapeutics Inc. is a biopharmaceutical company focused on developing targeted protein degradation therapies.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
75.0%1Y
95.8%3Y
11.0%5Y
Performance
78.6%1Y
69.7%3Y
74.7%5Y
Volatility
5191 M
Market cap (USD)
545,737
Daily traded volume (Shares)
39.69 / 38.29
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
